Skip to content

Global Sites

Search…

Search…

+91-22-2439 5200
info@jbcpl.com
Contact Us

J.B. Chemicals and Pharmaceuticals Ltd

Just another WordPress site

Our Foundation
Our Manufacturing
Our Science
Our Therapies
- Therapies at JB
- International Portfolio
Our Global Presence
- JB Pharma Worldwide
- International Partnerships
Investor Information
Media
- Press Releases
- Media Kit
Careers

Close

Global Sites

Search…

Search…

+91-22-2439 5200
info@jbcpl.com
Contact Us

Our Foundation
Our Manufacturing
Our Science
Our Therapies
- Therapies at JB
- International Portfolio
Our Global Presence
- JB Pharma Worldwide
- International Partnerships
Investor Information
Media
- Press Releases
- Media Kit
Careers

Year: FY22-23

Notice of Board Meeting for Audited Financial Results and Dividend, if any

Disclosure of material event – Update on Assignment of Trademark for Azmarda® indicated for heart failure patients with reduced ejection fraction (HfrEF) from Novartis AG, Switzerland for India

Assignment of Trademark for Azmarda® from Novartis AG, Switzerland for India

Search…

Recent Posts

ts
Healthcare
Education
Technology
Dosage Forms

Recent Comments

Archives

July 2021
June 2021

Categories

About us
Investors
Manufacturing Excellence
Media Center
Offerings
Social
Uncategorized

Meta

Log in
Entries feed
Comments feed
WordPress.org

Request a Call Back
Email us
Subscribe to our Newsletter

ABOUT US

Our Manufacturing
Our Responsibility
JB Worldwide
International Partnerships
History
Management Team
Board of Directors

Contact Us

Cnergy IT Park,

Unit A2, 3rd floor & Unit A, 8th floor,
Appa Saheb Marathe Marg, Prabhadevi,
Mumbai 400 025.

Tel: 91-22-2439 5200 / 2439 5500
Fax: 91-22-2431 5331 / 2431 5334
Email: info@jbcpl.com

Copyright
Privacy Policy

OFFERINGS

International Portfolio
R&D Innovation
Radio Diagnostics
Lozenges
API

Therapies at JB

Gastroenterology
Hypertension
Diabetes
Dermatology
Nephrology
Wound Care
Anti-Infectives
Pharmacovigilance

INVESTORS

Quarterly Results
Investor Presentations
Annual Reports
Investor Resources
Press Releases
Shareholders' Corner
Financial Information

Media Center

Press Releases
Media Contact

CAREERS

Life at JB
Join Us
Privacy Policy
Disclaimer
Sitemap

© 2020 - 2022 J.B. Chemicals and Pharmaceuticals Ltd. All rights reserved.

Website Maintain by SOL Digital